ATRIP
protein-codingATR interacting protein, the group of Armadillo like helical domain containing
Gene summary
This gene encodes an essential component of the DNA damage checkpoint. The encoded protein binds to single-stranded DNA coated with replication protein A. The protein also interacts with the ataxia telangiectasia and Rad3 related protein kinase, resulting in its accumulation at intranuclear foci induced by DNA damage. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~20.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0019342
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0019342
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007254
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0016419
Submitter: ClinGen
*ATRIP* was first reported concerning autosomal dominant inheritance and breast cancer susceptibility in 2023 (Cybulski C, et al., PMID: 36977412). Breast cancer (referring to mammary carcinoma) is histopathological and almost certainly etiologically and genetically heterogeneous. Familial occurrence has indicated important genetic factors (OMIM 114480). Per the criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism, inheritance pattern, or phenotypic variability. One variant (*ATRIP*:c.1152_1155del) reported in breast cancer patients in one publication (PMID: 36977412) is included in this curation. More evidence is available in the literature (Wilcox N, et al., PMID: 37592023), reported associations between protein-truncating variants in *ATRIP* and breast cancer (P < 1 × 10−4.). The mechanism of pathogenicity appears to be loss of function. This gene-disease relationship is also supported by experimental evidence from in vitro functional assays (PMID: 36977412). Immunohistochemistry and functional studies showed the *ATRIP* c.1152_1155del variant allele is weakly expressed compared to the wild-type allele, and truncated ATRIP fails to perform its normal function to prevent replicative stress. In summary, limited evidence supports the relationship between *ATRIP* and autosomal dominant inheritance Breast cancer susceptibility. This relationship has been demonstrated in patients with monoallelic mutations in *ATRIP* (PMIDs: 36977412, 37592023). The ClinGen Hereditary Cancer GCEP approved this classification on the meeting date of May 24, 2024 (SOP Version 10).
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ATRIP variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_130384.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 16 | 354 | 2 | 372 | ||
| missense | 809 | 75 | 2 | 886 | ||
| nonsense | 17 | 17 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 20 | 20 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 13 | 14 | |||
| Total | 0 | 1 | 876 | 429 | 4 | 1310 |
Highest pathogenic variant AF is 0.0000032575879
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_569055.1 | 13 | MANE Select | |
| Ensembl | ENSP00000323099.3 | 13 | MANE Select | |
| RefSeq | NP_001257951.1 | 11 | Standard | |
| RefSeq | NP_001257952.1 | 12 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Fanconi anemia pathway - Homo sapiens (human)
- miRNA Regulation of DNA Damage Response
- DNA Damage Response
- HDR through Single Strand Annealing (SSA)
- HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)
Biological Process
- DNA damage checkpoint
- DNA replication
- interstrand cross-link repair
Molecular Function
- protein binding
- K63-linked polyubiquitin modification-dependent protein binding
Cellular Component
- nucleus
- nucleoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000320211
- Coding exons
- 13
- Length
- 19002
- Individuals with no LoFs
- 125701
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 47
- Defined
- 125748
- p
- 0.000187
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.05 | 361 | 422 | 0.856 | 0.0000217 | 5093 |
| Missense (PolyPhen) | 108 | 133.98 | 0.80607 | 1725 | ||
| Synonymous | 1.09 | 164 | 183 | 0.897 | 0.0000101 | 1655 |
| Loss of Function | 3.22 | 14 | 34.3 | 0.408 | 0.00000173 | 400 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00060 | 0.00060 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00020 | 0.00020 | rare |
| South Asian | 0.00017 | 0.00016 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Required for checkpoint signaling after DNA damage. Required for ATR expression, possibly by stabilizing the protein. {ECO:0000269|PubMed:12791985}.;
Recessive Scores
- pRec
- 0.205
Intolerance Scores
- LoFtool
- 0.793
- RVIS EVS
- -0.75
- RVIS percentile EVS
- 13.74
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- N
- Indispensability score
- 0.460
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |